Age-related androgen deficiency and type 2 diabetes.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Ryan GJ;Ryan GJ; Jobe LJ
  • Source:
    Journal of pharmacy practice [J Pharm Pract] 2011 Jun; Vol. 24 (3), pp. 316-22. Date of Electronic Publication: 2011 Apr 14.
  • Publication Type:
    Journal Article; Review
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Sage Publications Country of Publication: United States NLM ID: 8900945 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-1937 (Electronic) Linking ISSN: 08971900 NLM ISO Abbreviation: J Pharm Pract Subsets: MEDLINE
    • Publication Information:
      Publication: <2002-> : Thousand Oaks, Calif. : Sage Publications
      Original Publication: [Philadelphia, PA] : W.B. Saunders, [1988]-
    • Subject Terms:
    • Abstract:
      There is a higher prevalence of low testosterone levels in males with type 2 diabetes compared to those without. Additionally, there is evidence that low testosterone levels may predict the development of type 2 diabetes. Symptoms of hypogonadism include decreased libido, decreased bone mineral density (BMD), and decreased lean muscle mass. The majority of the published cases in men with diabetes were attributed to age-related idiopathic hypogonadotropic hypogonadism. This paper reviews the link between type 2 diabetes and age-related hypogonadism and the treatment options for hypogonadism. Pharmacists who provide care for males with diabetes should be aware of the increased incidence of hypogonadism, know how to screen for it, and be able to recommend appropriate therapy.
    • Accession Number:
      0 (Androgens)
      3XMK78S47O (Testosterone)
    • Publication Date:
      Date Created: 20110617 Date Completed: 20120514 Latest Revision: 20131121
    • Publication Date:
      20231215
    • Accession Number:
      10.1177/0897190010397719
    • Accession Number:
      21676855